Stem Cell Therapy Safe in Macular Degeneration (CME/CE)
(MedPage Today) -- In the first application of its kind, human embryonic stem cells were safely used to treat macular degeneration in two patients, researchers reported.

Glasses, Patching Work for Rogue Form of Lazy Eye (CME/CE)
(MedPage Today) -- Refractive correction followed by patching helped kids with a particularly difficult-to-treat form of amblyopia, according to a small, prospective trial.

Dilated Eye Exams Cost Effective for Seniors (CME/CE)
(MedPage Today) -- Replacing the currently recommended visual acuity screening at the time of enrollment in Medicare with coverage for a dilated eye examination would be very cost effective, a simulation model suggested.

Daily Aspirin Tied to Eye Disorder (CME/CE)
(MedPage Today) -- Daily aspirin use may protect the heart but hurt the eyes, boosting the risk of age-related macular degeneration, researchers found.

Male Gender and Obesity Up Risk for Postop Blindness (CME/CE)
(MedPage Today) -- Men and heavier patients who have spine surgery may be at a greater risk for postoperative blindness, researchers found.

FDA to Study Complication of Cataract Surgery
WASHINGTON (MedPage Today) -- A rare but potentially serious complication of cataract surgery has caught the attention of the FDA, which has launched a monitoring program to prevent outbreaks of toxic anterior segment syndrome (TASS).

FDA Issues Second Contact Lens Recall
WASHINGTON (MedPage Today) -- The FDA has issued a class I recall — the agency’s most serious — for a second brand of CooperVision’s AVAIRA Aquaform contact lenses that may cause serious eye injury.

Surgery Outcomes Better With Some Fat on the Bones (CME/CE)
(MedPage Today) -- Surgical patients with a body mass index at the lower end of the normal range were more likely to die within 30 days of the procedure than those in the moderately overweight range, researchers found.

FDA Approves Eylea for Macular Degeneration
(MedPage Today) -- The FDA has approved a first-in-class drug, aflibercept (Eylea), for "wet" age-related macular degeneration, its manufacturer announced.

Genetic Testing for Eye Tumor Cuts Surveillance Costs (CME/CE)
(MedPage Today) -- Genetic testing of children with retinoblastoma and their families greatly reduced unnecessary and expensive clinical surveillance among potentially at-risk family members, a study suggested.